Xalatan (latanoprost) is now approved for the INITIAL treatment of glaucoma

February 2003

Xalatan (latanoprost) is now approved for the INITIAL treatment of glaucoma.

For years, topical beta-blockers (timolol, etc) were preferred. But respiratory problems and bradycardia are a concern.

Xalatan works at least as well as timolol...and has fewer systemic effects.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote